Director

• Serve as primary business partner and strategic advisor to SVP, Portfolio Development, SVP, GRAS and VP, Portfolio and Operations Excellence to shape and communicate portfolio development strategies and milestones, ensuring alignment with business objectives and external stakeholder expectations.
• Develop and execute communication plans for significant pipeline milestones, including clinical trial initiations, data readouts, and product approvals in partnership with R&D and commercial colleagues.
• Oversee the creation and dissemination of clear, compliant, and timely communications regarding clinical trial progress, results, and implications for patients and partners.
• Serve as a key partner to regulatory policy team providing strategic counsel on advocacy opportunities, and stakeholder engagement.
• Provides leadership and oversight into the development and review of key communications materials for portfolio milestones, ensuring alignment with corporate messaging and standards.
• Enhance the company’s reputation by engaging proactively with local biotech stakeholders, academic institutions, and industry groups, positioning the company as a leader in innovation and responsible R&D.
• Identify, assess, and manage potential issues and crises affecting R&D, coordinating rapid and effective responses to protect the company's reputation and interests.
• Evaluate and report on the performance of key corporate affairs activities, providing updates and analysis to leadership.
• Build pride and understanding across CSL about our pipeline and build a culture across R&D that reinforces our R&D 2.0 transformation goals.
• Manage budget allocations for specific projects or initiatives within the corporate affairs function, ensuring effective use of resources.

Associate Director, Corporate & External Affairs, R&D Portfolio

Executive Underwriter, AVP – Underwriting Director, Large Casualty

Associate Director – Medical Science Liaison, Mid Atlantic GI/Thoracic

Associate Director, Statistics – Oncology

Director, Access Strategy – Dupixent, Rhinology, Allergy and Gastroenterology